Icu Medical Inc
ICUI- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0000883984
In the last 90 days, Icu Medical Inc insiders filed 0 open-market purchases and 7 sales; 288 institutions reported holding it in 13F filings for Q2 2026, worth $3.82B in total; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Icu Medical Inc insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 7 filings
- 6 insiders, $6.63M in total
- Insiders trading
- 6
- Net value
- −$6.63M
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Icu Medical Inc, current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Sanzone Virginia Ruth | VP, General Counsel | 14,604 | Sep 3, 2026 | 5 |
| Bonnell Brian Michael | Chief Financial Officer | 56,062 | Sep 1, 2026 | 4 |
| Woolson Daniel | VP, GM-Infusion Capital | 17,062 | Aug 13, 2026 | 5 |
| Sousa Ben | Chief Information Officer | 3,076 | Aug 12, 2026 | 3 |
| Voigtlander Christian B. | Chief Operating Officer | 37,377 | Aug 11, 2026 | 3 |
| Finney Elisha W | Director | 4,871 | Aug 11, 2026 | 3 |
| Hoffmeister David F | Director | 6,004 | May 13, 2026 | 1 |
| Kennedy Kolleen T | Director | 4,539 | May 13, 2026 | 1 |
| Abbey Donald | Director | 6,004 | May 13, 2026 | 2 |
| Greenberg David C. | Director | 9,214 | May 13, 2026 | 1 |
| Hernandez Laurie | Director | 4,862 | May 13, 2026 | 1 |
| Jain Vivek | Chairman and CEO | 126,833 | Mar 16, 2026 | 2 |
| Lopez George A | Director | 877,343Indirect | Mar 14, 2024 | 0 |
| Smiths Group PLC | Other: Former 10% Owner | 1,670,000Indirect | Mar 1, 2024 | 0 |
| Smiths Group International Holdings Ltd | Other: Former 10% Owner | 1,670,000 | Mar 1, 2024 | 0 |
| McGrody Kevin J | Chief Accounting Officer | 4,846 | Mar 8, 2022 | 0 |
| Swinney Robert S | Director | 20,816 | Sep 15, 2021 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 30, 2025 (view filing) | May 30 | Same day | Sanzone Virginia RuthVP, General Counsel | SSale | −700 | $133.62 | −$93.5K | −9.9%6.39K after | |
| Aug 14, 2025 (view filing) | Aug 14 | Same day | Jain VivekChairman and CEO | PPurchase | +21.9K | $112.83 | +$2.47M | +20.3%130.1K after | 2 lots |
| Aug 27, 2025 (view filing) | Aug 27 | Same day | Greenberg David C.Director | PPurchase | +1.20K | $126.41 | +$151.7K | +17.8%7.96K after | 2 lots |
| Nov 12, 2025 (view filing) | Nov 11 | 1 day | Finney Elisha WDirector | SSale | −1.28K | $140.42 | −$180.4K | −24.3%4.00K after | |
| Nov 12, 2025 (view filing) | Nov 11 | 1 day | Sanzone Virginia RuthVP, General Counsel | SSale | −930 | $142.35 | −$132.4K | −14.6%5.46K after | |
| Nov 25, 2025 (view filing) | Nov 25 | Same day | Woolson DanielVP, GM-Infusion Capital | SSale | −2.90K | $152.35 | −$441.4K | −20.4%11.3K after | |
| May 13, 2026 (view filing) | May 12 | 1 day | Greenberg David C.Director | SSale | −2.42K | $122.91 | −$297.9K | −23.3%7.96K after | |
| May 15, 2026 (view filing) | May 14 | 1 day | Sanzone Virginia RuthVP, General Counsel | SSale | −2.45K | $124.08 | −$303.6K | −11.2%19.5K after | |
| May 22, 2026 (view filing) | May 22 | Same day | Woolson DanielPresident | SSale | −2.12K | $132.21 | −$280.7K | −8.6%22.5K after | |
| Aug 11, 2026 (view filing)5:59 PM ET | Aug 11 | Same day | Finney Elisha WDirector | SSale | −378 | $182.48 | −$69.0K | −7.2%4.87K after | |
| Aug 11, 2026 (view filing)6:18 PM ET | Aug 11 | Same day | Voigtlander Christian B.Chief Operating Officer | SSale | −8.93K | $182.93 | −$1.63M | −19.3%37.4K after | |
| Aug 12, 2026 (view filing)4:33 PM ET | Aug 12 | Same day | Sousa BenChief Information Officer | SSale | −2.25K | $178.32 | −$401.2K | −42.2%3.08K after | |
| Aug 13, 2026 (view filing)6:56 PM ET | Aug 13 | Same day | Woolson DanielVP, GM-Infusion Capital | SSale | −5.42K | $181.33 | −$982.3K | −24.1%17.1K after | |
| Aug 31, 2026 (view filing)4:43 PM ET | Aug 31 | Same day | Bonnell Brian MichaelChief Financial Officer | SSale | −9.31K | $172.79 | −$1.61M | −13.0%62.4K after | 4 lots10b5-1 |
| Sep 1, 2026 (view filing)5:21 PM ET | Sep 1 | Same day | Bonnell Brian MichaelChief Financial Officer | SSale | −6.38K | $175.00 | −$1.12M | −10.2%56.1K after | 10b5-1 |
| Sep 3, 2026 (view filing)6:29 PM ET | Sep 3 | Same day | Sanzone Virginia RuthVP, General Counsel | SSale | −4.86K | $168.69 | −$819.2K | −25.0%14.6K after | 4 lots10b5-1 |